1. Home
  2. MNY vs NEPH Comparison

MNY vs NEPH Comparison

Compare MNY & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoneyHero Limited

MNY

MoneyHero Limited

HOLD

Current Price

$0.92

Market Cap

41.9M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.50

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNY
NEPH
Founded
2014
1997
Country
Singapore
United States
Employees
240
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
40.1M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
MNY
NEPH
Price
$0.92
$4.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$6.00
AVG Volume (30 Days)
11.2K
8.6K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.01
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
$19.58
$11.58
P/E Ratio
N/A
$359.00
Revenue Growth
N/A
32.67
52 Week Low
$0.78
$2.66
52 Week High
$2.40
$6.42

Technical Indicators

Market Signals
Indicator
MNY
NEPH
Relative Strength Index (RSI) 38.34 52.48
Support Level $0.78 $3.19
Resistance Level $1.03 $3.78
Average True Range (ATR) 0.05 0.23
MACD 0.00 -0.01
Stochastic Oscillator 0.00 60.00

Price Performance

Historical Comparison
MNY
NEPH

About MNY MoneyHero Limited

MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: